Prescrire Int. 2003 Dec;12(68):211-3.
(1) First-line treatment for both acute and chronic pain is paracetamol or, if necessary, ibuprofen, a nonsteroidal antiinflammatory drug. If relief is inadequate, the best option is a combination of paracetamol with codeine (a weak opiate). (2) A fixed-dose combination of paracetamol (325 mg) and tramadol (37.5 mg), a weak opiate, arrived on the French market in May 2003. (3) In the acute setting, three trials in a total of 1197 patients showed that a single dose of the paracetamol 650 mg + tramadol 75 mg combination after dental surgery was no more effective than ibuprofen 400 mg. Compared with each drug used alone, the paracetamol + tramadol combination prolongs the analgesic effect but does not increase its intensity. (4) A trial after gynaecological surgery and another trial after orthopaedic surgery showed that a single dose of paracetamol 975 mg + tramadol 112.5 mg had similar efficacy to tramadol alone at 112.5 mg. (5) In the chronic setting, we found no trials comparing the paracetamol + tramadol combination with each drug used alone. A comparative double-blind trial in 462 patients with low back pain or osteoarthritic pain showed no difference in efficacy between paracetamol 325 mg + tramadol 37.5 mg and paracetamol 300 mg + codeine 30 mg. (6) The main adverse effects of the paracetamol + tramadol combination are the same as other weak opiates: nausea, vomiting, dizziness, headache, drowsiness and constipation. Tramadol carries a higher risk of drug interactions than codeine. (7) In practice, the paracetamol + tramadol combination offers patients no advantages relative to standard analgesics.
(1) 急性和慢性疼痛的一线治疗药物是对乙酰氨基酚,必要时可使用布洛芬,一种非甾体抗炎药。若疼痛缓解不充分,最佳选择是对乙酰氨基酚与可待因(一种弱阿片类药物)的组合。(2) 对乙酰氨基酚(325毫克)与曲马多(37.5毫克)的固定剂量组合,一种弱阿片类药物,于2003年5月进入法国市场。(3) 在急性情况下,三项共纳入1197名患者的试验表明,牙科手术后单次服用对乙酰氨基酚650毫克+曲马多75毫克的组合并不比400毫克布洛芬更有效。与单独使用每种药物相比,对乙酰氨基酚+曲马多组合可延长镇痛效果,但不会增强其强度。(4) 一项妇科手术后试验和另一项骨科手术后试验表明,单次服用对乙酰氨基酚975毫克+曲马多112.5毫克与单独使用112.5毫克曲马多的疗效相似。(5) 在慢性情况下,我们未发现将对乙酰氨基酚+曲马多组合与单独使用每种药物进行比较的试验。一项针对462名腰痛或骨关节炎疼痛患者的双盲对照试验表明,对乙酰氨基酚325毫克+曲马多37.5毫克与对乙酰氨基酚300毫克+可待因30毫克在疗效上无差异。(6) 对乙酰氨基酚+曲马多组合的主要不良反应与其他弱阿片类药物相同:恶心、呕吐、头晕、头痛、嗜睡和便秘。曲马多发生药物相互作用的风险高于可待因。(7) 在实际应用中,对乙酰氨基酚+曲马多组合相对于标准镇痛药并未给患者带来优势。